B.Riley Upgrades Madrigal Pharmaceuticals (MDGL) to Neutral
Tweet Send to a Friend
(Updated - March 15, 2024 4:13 AM EDT)
B.Riley analyst Mayank Mamtani upgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Mayank Mamtani upgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
